Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer

Published:2017-06-30 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Zheng Wujian,Feng Qi,Liu Jiao,Guo Yanke,Gao Lvfen,Li Ruiman,Xu Meng,Yan Guizhen,Yin Zhinan,Zhang Shuai,Liu Shuangping,Shan Changliang

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Real-time monitoring of cisplatin-induced cell death.;Alborzinia;PLoS ONE,2011

2. Regulation of cancer cell metabolism.;Cairns;Nat. Rev. Cancer,2011

3. Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death.;Catanzaro;Oncotarget,2015

4. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.;Chen;Oncotarget,2016

5. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1.;Cheng;Mol. Cell. Biochem.,2016

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of pentose phosphate pathway in bladder cancer;Metabolomics of Bladder Cancer;2025

2. 6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells;Cancer Letters;2024-10

3. Plasma GPI and PGD are associated with vascular normalization and may serve as novel prognostic biomarkers for lung adenocarcinoma: Multi-omics and multi-dimensional analysis;Journal of Proteomics;2024-08

4. The role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia;JVS-Vascular Science;2024-08

5. Malate, a natural inhibitor of 6PGD, improves the efficacy of chemotherapy in lung cancer;Lung Cancer;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3